Stacy R. Lindborg, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stacy R. Lindborg, Ph.D.
Stacy R. Lindborg, Ph.D. is recorded as CEO at Imunon, Inc. (IMNN). Imunon, Inc. reported in an 8-K filed May 8, 2024 that Stacy R. Lindborg, Ph.D. was appointed President and Chief Executive Officer, effective May 13, 2024.
“On May 8, 2024, Imunon, Inc. (the “Company”) announced the appointment of Stacy R. Lindborg, Ph.D., as President and Chief Executive Officer of the Company, effective as of May 13, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-05-13–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Imunon, Inc.
Other people whose current roles at this company are on record from its filings.
- Corinne Le Goff CEO, Board Member
- Michael Tardugno CEO, Chairman
- Stacy Lindborg CEO, Board Member
- Stacy R. Lindborg CEO, Board Member
- Michael H. Tardugno Chairman
- David Gaiero CFO
- Josh Blacher CFO
- Kimberly Graper CFO
- Susan Eylward General Counsel
- Christine A. Pellizzari Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.